Hepatocyte growth factor in renal disease: cause or cure?

被引:6
|
作者
Laping, NJ [1 ]
机构
[1] SmithKline Beecham Pharmaceut, Renal Pharmacol, King Of Prussia, PA 19406 USA
关键词
hepatocyte growth factor; c-met; renal disease; diabetes; glomerulosclerosis;
D O I
10.1007/s000180050438
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocyte growth factor (HGF) is an injury-released growth factor with diverse effects on epithelial and endothelial cells. These effects include proliferation, migration, extracellular matrix production and tubulogenesis. These activities allow HGF to function as an organizer of repair processes that bring about restoration of tubular function following renal injury. However, while HGF has been demonstrated to accelerate recovery of renal function after an acute insult. prolonged exposure to elevated levels of HGF can reduce renal function and may contribute to progressive renal disease. This review will describe the cellular activities of HGF, how they pertain to renal repair and the therapeutic application of regulating HGF activity in acute versus chronic renal disease.
引用
收藏
页码:371 / 377
页数:7
相关论文
共 50 条
  • [21] Expression of hepatocyte growth factor in the serum and cerebrospinal fluid of patients with Parkinson's disease
    Salehi, Zivar
    Rajaei, Farzad
    JOURNAL OF CLINICAL NEUROSCIENCE, 2010, 17 (12) : 1553 - 1556
  • [22] Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease
    Wader, Karin F.
    Fagerli, Unn-Merete
    Borset, Magne
    Lydersen, Stian
    Hov, Hakon
    Sundan, Anders
    Bofin, Anna
    Waage, Anders
    HISTOPATHOLOGY, 2012, 60 (03) : 443 - 451
  • [23] Hepatocyte Growth Factor is a Potential Lymphangiogenic Factor; Clinical Implications
    Jiang, Wen G.
    Sanders, Andrew J.
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2011, 6 (02) : 168 - 172
  • [24] Physiological and pathophysiological role of the hepatocyte growth factor
    Rodriguez-Fragoso, L
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1998, 50 (04): : 355 - 367
  • [25] Hepatocyte growth factor/scatter factor and prostate cancer: a review
    Hurle, RA
    Davies, G
    Parr, C
    Mason, MD
    Jenkins, SA
    Kynaston, HG
    Jiang, WG
    HISTOLOGY AND HISTOPATHOLOGY, 2005, 20 (04) : 1339 - 1349
  • [26] Expression of hepatocyte growth factor and its receptor C-met in acquired renal cystic disease associated with renal cell carcinoma
    Konda, R
    Sato, H
    Hatafuku, F
    Nozawa, T
    Ioritani, N
    Fujioka, T
    JOURNAL OF UROLOGY, 2004, 171 (06): : 2166 - 2170
  • [27] Hepatocyte growth factor and c-met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: An evaluation of their expression as prognostic markers
    Takanami, I
    Tanana, F
    Hashizume, T
    Kikuchi, K
    Yamamoto, Y
    Yamamoto, T
    Kodaira, S
    ONCOLOGY, 1996, 53 (05) : 392 - 397
  • [28] Hepatocyte growth factor shows benefits for patients with chronic renal failure induced type 2 diabetes
    Yu, Gan
    Hua, Zhou Hui
    Li, Zhang
    Wei, Li Tong
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (09): : 3837 - 3844
  • [29] Increased urinary hepatocyte growth factor excretion in human acute renal failure
    Taman, M
    Liu, Y
    Tolbert, E
    Dworkin, LD
    CLINICAL NEPHROLOGY, 1997, 48 (04) : 241 - 245
  • [30] Differential regulation of thalamic and cortical axonal growth by hepatocyte growth factor/scatter factor
    Powell, EM
    Mühlfriedel, S
    Bolz, J
    Levitt, P
    DEVELOPMENTAL NEUROSCIENCE, 2003, 25 (2-4) : 197 - 206